☆ 4.6 Article

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

ESMO OPEN (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report

Massimo Breccia et al.

Summary: Limited information is available on the impact of the COVID-19 pandemic on the management of chronic myeloid leukaemia (CML). A retrospective study in Italy showed that during the pandemic, a majority of CML patients were infected with SARS-CoV-2, some stopped TKI therapy, and 12 patients died from COVID-19, highlighting the need for enhanced protection and management of CML patients.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Article Immunology

The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection

Allen W. Zhang et al.

Summary: The use of G-CSF in cancer patients with COVID-19 may increase the risk of hospitalization, respiratory failure, and death. Careful consideration should be given to the potential risks and benefits of G-CSF treatment in neutropenic cancer patients with COVID-19.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Chanu Rhee et al.

Summary: SARS-CoV-2 is most contagious around symptom onset, with infectivity rapidly decreasing to near-zero afterwards; mild-moderately ill patients can safely discontinue isolation after about 10 days, while severely-critically ill and immunocompromised patients may need 15 days. The longest duration associated with replication-competent virus is 20 days.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Hematology

Hemostatic alterations in COVID-19

Flora Peyvandi et al.

HAEMATOLOGICA (2021)

添加到收藏夹

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Article Oncology

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui et al.

Summary: The study found a high risk of mortality among MPN patients during COVID-19 infection, especially in MF patients and those discontinuing Ruxo treatment. Further investigation is needed on the role of Ruxo treatment and its interruption in affecting mortality in MPN patients with COVID-19.

LEUKEMIA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen et al.

Summary: The study found that the median duration of shedding infectious virus in COVID-19 patients is 8 days, dropping below 5% after 15.2 days post onset of symptoms. High viral loads are associated with infectious SARS-CoV-2 isolation, while high serum neutralizing antibody titres are associated with non-infectious SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Hematology

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

Akshay Sharma et al.

Summary: This study examined the characteristics and outcomes of HSCT recipients after developing COVID-19. It found that recipients of autologous and allogeneic HSCT who develop COVID-19 have poor overall survival rates. Factors such as age, sex, and time since transplantation were associated with higher risk of mortality in HSCT recipients.

LANCET HAEMATOLOGY (2021)

添加到收藏夹

Article Oncology

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. A. Dimopoulos et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

Paloma Merino et al.

Summary: The study aimed to evaluate the performance of the PanbioRT COVID-19 Ag Rapid Test Device in detecting SARS-CoV-2 in patients with COVID-19 symptoms. The results showed that PanbioRT performed well clinically, especially for patients with a shorter clinical course or a higher viral load.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Letter Oncology

Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors

Jacobo Rogado et al.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Review Infectious Diseases

Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies

Kamelia R. Stanoeva et al.

Summary: This study reviewed current knowledge on COVID-19 molecular detection, summarizing the kinetics of SARS-CoV-2 infection in various clinical samples. It emphasized the importance of choosing the most appropriate sample type for molecular testing and outlined directions for future well-documented systematic studies.

EUROSURVEILLANCE (2021)

添加到收藏夹

Article Infectious Diseases

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

Annalisa Mondi et al.

Summary: This study found that COVID-19 patients with lymphopenia, severe respiratory disease, comorbidities, and elevated D-dimer levels upon admission were more likely to experience prolonged viral shedding. Prompt hospitalization and achieving viral clearance were associated with better clinical outcomes.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

Nira R. Pollock et al.

Summary: The study evaluated the performance of the Abbott BinaxNOW COVID-19 Ag card in a community testing site and found high sensitivity in newly symptomatic adults, but lower sensitivity in children and asymptomatic individuals, revealing potential limitations of the BinaxNOW test.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Virology

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection

L. Courtellemont et al.

Summary: The study evaluated a new antigen-based rapid detection test in a real-life setting, showing high sensitivity and specificity. These rapid tests may be particularly useful for large-scale screening in emergency departments, low-resource settings, and airports.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Review Oncology

Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group

Evangelos Terpos et al.

Summary: The Bone Working Group of the International Myeloma Working Group recommends the use of zoledronic acid as the preferred bone-targeted agent for patients with newly diagnosed multiple myeloma. Denosumab can be considered for patients with renal impairment. Cement augmentation is effective for painful vertebral compression fractures.

LANCET ONCOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis

Vania M. Moreira et al.

Summary: This study critically appraised and compared the clinical performance of various specimens for SARS-CoV-2 detection, with saliva showing the highest accuracy and being identified as the best alternative to the current standard swab samples.

DIAGNOSTICS (2021)

添加到收藏夹

Article Hematology

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Yair Herishanu et al.

Summary: Patients with chronic lymphocytic leukemia have a significantly impaired antibody response to the BNT162b2 mRNA COVID-19 vaccine, which is influenced by disease activity and treatment.

BLOOD (2021)

添加到收藏夹

Letter Hematology

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Evangelos Terpos et al.

BLOOD (2021)

添加到收藏夹

Letter Hematology

Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Patrick Harrington et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Oncology

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

Nicola Giesen et al.

Summary: The global spread of SARS-CoV-2 and COVID-19 presents unique challenges to medical staff, patients, and their families, particularly for cancer patients. This concise update provides evidence-based recommendations for rapid diagnostics, viral shedding, vaccination, and therapy of COVID-19 in cancer patients, aiming to improve clinical management for this specific population.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Infectious Diseases

Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients

Lis Thommes et al.

Summary: The study evaluated the clinical performance of four commercially available antigen tests in hospitalized COVID-19 patients. Most antigen tests had sufficient sensitivity to identify subjects infected with SARS-CoV-2 and with transmissible infection, but may not accurately identify patients who have lost infectivity.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Virology

Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection

Felipe Perez-Garcia et al.

Summary: The study showed that both CerTest and Panbio Ag-RDTs demonstrated excellent specificity but lower sensitivity. Higher sensitivity was observed when Ct values were <25, while significantly lower sensitivity was noted with Ct >25. Samples taken within the first 5 days of symptom onset showed higher sensitivity for both tests. Both Ag-RDTs exhibited excellent agreement with each other and with PCR for samples with high viral loads or those taken within the first 5 days after symptom onset.

JOURNAL OF CLINICAL VIROLOGY (2021)

添加到收藏夹

Article Oncology

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

Fulvia Pimpinelli et al.

Summary: The study assessed the safety and immunogenicity of the BNT162b2 mRNA vaccine in hematological patients, finding lower response rates in multiple myeloma patients. It suggests that these patients should continue to maintain protective measures and monitor vaccine effectiveness post-vaccination.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Oncology

COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Lindsey E. Roeker et al.

LEUKEMIA (2021)

添加到收藏夹

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Kate-Lynn Muir et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer

Jerald Sadoff et al.

Summary: The manufacturer responds to recent reports of thrombosis and severe thrombocytopenia in recipients of the Ad26.COV2.S vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Hematology

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

Sarah Bird et al.

LANCET HAEMATOLOGY (2021)

添加到收藏夹

Article Hematology

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies

Katrin Herzog Tzarfati et al.

Summary: Patients with hematologic malignancies have a reduced immune response to the COVID-19 vaccine, with lower seropositivity rates and antibody titers, increasing their risk for severe infection.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Hematology

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies

Paola Ghione et al.

BLOOD (2021)

添加到收藏夹

Article Hematology

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia

Patrick Harrington et al.

Summary: This study found that most patients with CML developed antibodies and polyfunctional T-cell responses after receiving a single dose of the SARS-CoV-2 BNT162b2 vaccine, demonstrating good immunogenicity in this patient population compared to those with solid tumors or lymphoid hematological malignancies.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Hematology

Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients

Magdalena Benda et al.

Summary: The study evaluated the serological response, predictive markers, and safety of BNT162b2 in haemato-oncological patients. Results showed that over 70% of oncological patients and around 70% of haematological patients developed antibodies after vaccination, with some patients at risk of serological non-response. Vaccination was well tolerated with low risk of severe side effects.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Hematology

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies

Francesco Passamonti et al.

Summary: The study found a low rate of seroconversion in patients with hematological malignancies, possibly due to treatment-mediated immune dysfunction.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Letter Oncology

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Lee M. Greenberger et al.

CANCER CELL (2021)

添加到收藏夹

Letter Oncology

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

Oliver Van Oekelen et al.

CANCER CELL (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Kathryn F. Larson et al.

CIRCULATION (2021)

添加到收藏夹

Letter Oncology

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia

Fulvia Pimpinelli et al.

Summary: Among 42 Philadelphia negative myeloproliferative neoplasm patients receiving systemic active treatment, those with myelofibrosis showed significantly lower response to the anti-SARS-CoV-2 BNT162b2 vaccine compared to patients with essential thrombocythemia and polycythemia vera in terms of IgG titers and seroprotection rates. The ongoing treatment with Ruxolitinib in some patients may be associated with reduced vaccine immunogenicity, but further large prospective studies are needed to confirm this finding.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Letter Oncology

Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

Patrick Harrington et al.

LEUKEMIA (2021)

添加到收藏夹

Article Medicine, General & Internal

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Alex Bourguignon et al.

Summary: High-dose intravenous immune globulin (IVIG) combined with anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), showing a good response in reducing antibody-induced platelet activation, particularly in cases of VITT induced by ChAdOx1 nCoV-19 vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Evangelos Terpos et al.

Summary: Recent data shows suboptimal antibody response to COVID-19 vaccination in patients with hematological malignancies. Specifically, patients with multiple myeloma (MM) exhibit lower production of neutralizing antibodies (NAbs) after vaccination compared to healthy controls, especially when undergoing treatment with anti-CD38 or belamaf. Timely vaccination, possibly during treatment-free periods, is emphasized for this group of patients.

BLOOD CANCER JOURNAL (2021)

添加到收藏夹

Article Hematology

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

Kazimieras Maneikis et al.

Summary: Patients with haematological malignancies exhibit blunted and heterogeneous antibody responses after receiving the full course of BNT162b2 mRNA vaccination. Those actively treated with BTKIs, ruxolitinib, venetoclax, or anti-CD20 antibody therapies show the poorest responses, while patients who received tyrosine kinase inhibitors or various types of stem-cell transplantation had higher antibody responses. Severe breakthrough SARS-CoV-2 infections and deaths in fully vaccinated patients with haematological malignancies highlight the importance of continued adherence to non-pharmacological interventions and household vaccination.

LANCET HAEMATOLOGY (2021)

添加到收藏夹

Editorial Material Hematology

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Sean H. Lim et al.

LANCET HAEMATOLOGY (2021)

添加到收藏夹

Article Hematology

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

C. Perry et al.

Summary: Patients with B-cell non-Hodgkin lymphoma (B-NHL) undergoing R/Obi treatment have impaired humoral response to the BNT162b2 mRNA COVID-19 vaccine. Longer time since exposure to R/Obi is associated with improved response rates to the COVID-19 vaccine. Multi-variable analysis reveals predictors for a positive serological response.

BLOOD ADVANCES (2021)

添加到收藏夹

Article Hematology

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic

Martin Dreyling et al.

HEMASPHERE (2021)

添加到收藏夹

Article Hematology

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

Isabel Regalado-Artamendi et al.

Summary: This study examined the impact of COVID-19 on patients with lymphoma, finding that factors like age, confusion, urea concentration, and respiratory rate, as well as active disease, were associated with higher mortality risk. Additionally, continued presence of the virus after week six significantly increased mortality rates.

HEMASPHERE (2021)

添加到收藏夹

Article Medicine, General & Internal

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Alex Bourguignon et al.

Summary: The use of high-dose IVIG plus anticoagulation is recommended for the treatment of VITT, a rare side effect of adenoviral vector vaccines against Covid-19. Response to IVIG therapy in VITT patients showed reduced platelet activation and improvement in symptoms.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Oncology

Multiple myeloma: Role of autologous transplantation

Ioannis Ntanasis-Stathopoulos et al.

CANCER TREATMENT REVIEWS (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Oncology

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Sagar Lonial et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Hematology

Multiple myeloma: 2020 update on diagnosis, risk-stratification and management

S. Vincent Rajkumar

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Letter Hematology

Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?

Tamara Nawar et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Letter Oncology

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

A. Bayle et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Article Hematology

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients

Steven P. Treon et al.

BLOOD (2020)

添加到收藏夹

Letter Hematology

Successful prevention and screening strategies for COVID-19: focus on patients with haematologic diseases

Sung-Yeon Cho et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Review Infectious Diseases

Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials

Jessica J. Bartoszko et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)

添加到收藏夹

Article Immunology

Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study

Shaorui Hao et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Medicine, General & Internal

Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study

Joseph A. Lewnard et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Lennard Y. W. Lee et al.

LANCET (2020)

添加到收藏夹

Review Oncology

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

Evangelos Terpos et al.

LEUKEMIA (2020)

添加到收藏夹

Review Oncology

Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg

Katja C. Weisel et al.

ONCOLOGY RESEARCH AND TREATMENT (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Caring for patients with cancer in the COVID-19 era

Joris van de Haar et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Respiratory virus shedding in exhaled breath and efficacy of face masks

Nancy H. L. Leung et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

M. M. Arons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study

Benjamin J. Cowling et al.

LANCET PUBLIC HEALTH (2020)

添加到收藏夹

Article Hematology

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti et al.

LANCET HAEMATOLOGY (2020)

添加到收藏夹

Review Infectious Diseases

A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19

Sonia N. Rao et al.

INFECTIOUS DISEASES AND THERAPY (2020)

添加到收藏夹

Article Genetics & Heredity

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Yujiro Toyoshima et al.

JOURNAL OF HUMAN GENETICS (2020)

添加到收藏夹

Article Oncology

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

Julio Garcia-Suarez et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Letter Medicine, General & Internal

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

Anne L. Wyllie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Oncology

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

Joaquin Martinez-Lopez et al.

BLOOD CANCER JOURNAL (2020)

添加到收藏夹

Review Hematology

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Abi Vijenthira et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Ajai Chari et al.

BLOOD (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Victoria A. Avanzato et al.

CELL (2020)

添加到收藏夹

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Teresa Aydillo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Hematology

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub

William A. Wood et al.

BLOOD ADVANCES (2020)

添加到收藏夹

Article Immunology

Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease

Laura Matrajt et al.

EMERGING INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Hematology

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

Davide Rossi et al.

HEMASPHERE (2020)

添加到收藏夹

Article Hematology

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

Habte Yimer et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

添加到收藏夹

Article Infectious Diseases

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Malgorzata Mikulska et al.

LANCET INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Infectious Diseases

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Catherine Cordonnier et al.

LANCET INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Oncology

The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG)

Charalampia Kyriakou et al.

BLOOD CANCER JOURNAL (2019)

添加到收藏夹

Article Medicine, General & Internal

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau et al.

LANCET (2019)

添加到收藏夹

Article Hematology

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

Laura Rosinol et al.

BLOOD (2019)

添加到收藏夹

Article Medicine, General & Internal

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal et al.

LANCET (2019)

添加到收藏夹

Review Oncology

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

C. T. Rieger et al.

ANNALS OF ONCOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Drew J. Winston et al.

LANCET (2018)

添加到收藏夹

Article Oncology

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

Arjun Lakshman et al.

BLOOD CANCER JOURNAL (2018)

添加到收藏夹

Article Oncology

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events

Dirk H. Wijn et al.

EUROPEAN JOURNAL OF CANCER (2018)

添加到收藏夹

Article Medicine, General & Internal

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Meletios A. Dimopoulos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

Michel Attal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Hematology

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Evangelos Terpos et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Hematology

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Evangelos Terpos et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Review Oncology

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar et al.

LANCET ONCOLOGY (2014)

添加到收藏夹

Review Oncology

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

M. A. Dimopoulos et al.

LEUKEMIA (2014)

添加到收藏夹

Review Infectious Diseases

Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis

Charles R. Beck et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)

添加到收藏夹

Article Oncology

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease

Evangelos Terpos et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Review Public, Environmental & Occupational Health

Face masks to prevent transmission of influenza virus: a systematic review

B. J. Cowling et al.

EPIDEMIOLOGY AND INFECTION (2010)

添加到收藏夹

Article Geriatrics & Gerontology

Effect of Influenza Vaccination of Nursing Home Staff on Mortality of Residents: A Cluster-Randomized Trial

Magali Lemaitre et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)

添加到收藏夹

Article Hematology

Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

Roland Meisel et al.

BLOOD (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.